Asthma is a respiratory condition often stemming from childhood, characterized by difficulty
breathing and/or chest tightness. Current treatment options for both adults and children …

Asthma is a chronic respiratory disease that affects 339 million people worldwide and has a
considerable impact on the pediatric population. Asthma symptoms can be controlled by …

Introduction Asthma is a heterogeneous, multifactorial disease with multiple genetic and
environmental risk factors playing a role in pathogenesis and therapeutic response …

Asthma is a common chronic condition in children, where the response to treatment can be
heterogeneous within a population. Genetic variations may partly explain the inconsistent …

Asthma is one of the most common chronic diseases affecting children. Despite publicized
expert panels on asthma management and the availability of high-potency inhaled …

Personalized medicine, an approach to care in which individual characteristics are used for
targeting interventions and maximizing health outcomes, is rapidly becoming a reality for …

There is evidence that genetic factors are implicated in the observed differences in
therapeutic responses to the common classes of asthma therapy such as β2-agonists …

Asthma is a complex multifactorial disease and it is the most common chronic disease in
children. There is a high variability in response to asthma treatment, even in patients with …

It will be important to replicate previous genotypic associations in large clinical trial cohorts
as future pharmacogenetic studies continue to focus on genome-wide approaches and the …

Aim: International collaboration is needed to enable large-scale pharmacogenomics studies
in childhood asthma. Here, we describe the design of the Pharmacogenomics in Childhood …